Although the holiday season is a time for indulgence, the same cannot be said for those suffering from type 2 diabetes. Here are some ways to keep blood sugar levels normal during the festive season.
It might be a challenge trying to stay healthy during the holidays, with all the rich dishes being served every place. This is especially for type 2 diabetics, who have to maintain a strict diet in order to keep blood sugar levels at bay due to the lack of insulin being produced in their body. Fortunately, Express reports expert-recommended ways to keep blood sugar levels from spiking for type 2 diabetics, or anyone looking to cut down on their sugar intake this season.
One way is to swap chocolate and sweets for dried fruit and nuts. Dried fruit has natural sugars that will not wreak havoc on your blood sugar. Dried fruit also has fiber which is good for the digestive system as well. Nuts contain protein, and combining the two can help slow down the release of sugar.
Another way is to simply use sugar sparingly, especially in drinks. Experts recommend going for half sugar - half sweetener instead to keep blood sugar levels from spiking. In the same vein, go for sugar-free cocktails or mocktails.
A third way is to simply not skip meals, especially if you are playing host or hostess to friends and family during the Christmas season. Eat a good breakfast with fiber and protein to keep blood sugar levels from dropping, at least until lunch time.
If you are playing host or hostess to family and friends during the holidays, consider adding a certain vegetable to your salads or main courses that is shown to help keep blood sugar levels in check. Express reports that brussels sprouts, under the same vegetable family as cauliflower and kale, can help maintain healthy blood sugar levels, especially for type 2 diabetics.
This is because, like its other leafy relatives, brussels sprouts are rich in fiber, which is good for the digestive system and helps regulate bowel movements which in turn, prevents constipation. Brussels sprouts also contain alpha-lipoid acid, which is an antioxidant that is known for its possible effects on both blood sugar and insulin.


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 



